[ad_1]
NEW YORK, Feb. 05, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ:RETA) between November 9, 2020 and December 8, 2021, inclusive (the “Class Period”), of the important February 18, 2022 lead plaintiff deadline.
SO WHAT: If you purchased Reata Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Reata Pharmaceuticals class action, go to http://www.rosenlegal.com/cases-register-2230.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 18, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often firms, issuing notices do …
Full story available on Benzinga.com
[ad_2]
Source link
